Table 3.
Results of PD-L1 Expression and TPS Score Based on IHC
| Variables | Classification | PD-L1 expression | p-value | TPS score | p-value |
|---|---|---|---|---|---|
| N (%) | Mean ± SD | ||||
| Tumor groups | Classic | 11 (45.8%) | 0.2 | 23.25 ± 31.47 | 0.009 B |
| Nodular Sclerosis | 17 (36.9%) | 14.08 ± 22.89 | 0.012 W | ||
| Mixed Cellularity | 14 (60.9%) | 42.11 ± 35.05 | |||
| HL stage | Stage I | 6 (27.3%) | 0.15 | 8.33 ± 16.89 | 0.016 B & W |
| Stage II | 20 (51.3%) | 26.67 ± 32.44 | 0.0018 W | ||
| Stage III | 10 (55.5%) | 35.63 ± 33.86 | |||
| Stage IV | 13 (61.9%) | 39.41 ± 34.36 |
HL, Hodgkin's lymphoma; B, Brown-Forsythe; W, Welch`s Test